Protective effects of the polyphenol sesamin on allergen-induced T H2 responses and airway inflammation in mice

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Lin, Ching Huei ^a,b   Shen, Mei Lin ^a,b   Zhou, Ning ^a,b   Lee, Chen Chen ^c   Kao, Shung Te ^b   Wu, Dong Chuan ^a,b  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; MUCIN 5AC; OVALBUMIN; POLYPHENOL; SESAMIN; 1,3 DIOXOLANE DERIVATIVE; ALLERGEN; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; CYTOKINE; LIGNAN;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS MUCUS; CELL HYPERPLASIA; CELL INFILTRATION; CELL NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; EOSINOPHIL COUNT; GOBLET CELL; IMMUNOGLOBULIN BLOOD LEVEL; INFLAMMATORY CELL; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; OVALBUMIN-INDUCED AIRWAY INFLAMMATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ACTIVE TRANSPORT; ANIMAL; ASTHMA; BAGG ALBINO MOUSE; BLOOD; DRUG EFFECTS; EOSINOPHIL; IMMUNOLOGY; LUNG; METABOLISM; MUCUS; TH2 CELL;

ACTIVE TRANSPORT, CELL NUCLEUS; ALLERGENS; ANIMALS; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DIOXOLES; EOSINOPHILS; IMMUNOGLOBULIN E; LIGNANS; LUNG; MALE; MICE, INBRED BALB C; MUCUS; NF-KAPPA B; TH2 CELLS;

EID: 84899688915     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096091     Document Type: Article

References (69)

1. World Health Organization (2007) Global surveillance, prevention and control of chronic respiratory diseases: a comprehensive approach. World Health Organization.
2. Holgate ST (2008) Pathogenesis of asthma. Clinical and Experimental Allergy 38: 872-897.
3. Galli SJ, Tsai M, Piliponsky AM (2008) The development of allergic inflammation. Nature 454: 445-454.
4. Jarnicki AG, Fallon PG, (2003) T helper type-2 cytokine responses: potential therapeutic targets. Curr Opin Pharmacol 3: 449-455. (Pubitemid 36908949)
5. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, et al. (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263. (Pubitemid 29004075)
6. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, et al. (1998) Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261. (Pubitemid 29004074)
7. Gould HJ, Sutton BJ (2008) IgE in allergy and asthma today. Nat Rev Immunol 8: 205-217. (Pubitemid 351323292)
8. Rothenberg ME (1998) Eosinophilia. New England Journal of Medicine 338: 1592-1600.
9. Barnes PJ (2005) Molecular mechanisms and cellular effects of glucocorticosteroids. Immunol Allergy Clin North Am 25: 451-468.
10. Barnes PJ (2006) How corticosteroids control inflammation: Quintiles Prize Lecture 2005. British Journal of Pharmacology 148: 245-254.
11. Pignatti PF (2004) Trends in pharmacogenomics of drugs used in the treatment of asthma. Pharmacological Research 49: 343-349.
12. Cazzola M, Page CP, Rogliani P, Matera MG (2013) beta2-agonist therapy in lung disease. American Journal of Respiratory and Critical Care Medicine 187: 690-696.
13. Adcock IM, Caramori G, Chung KF (2008) New targets for drug development in asthma. Lancet 372: 1073-1087.
14. McIvor RA, Pizzichini E, Turner MO, Hussack P, Hargreave FE, et al. (1998) Potential masking effects of salmeterol on airway inflammation in asthma. American Journal of Respiratory and Critical Care Medicine 158: 924-930. (Pubitemid 28449462)
15. Saura-Calixto F, Serrano J, Goñi I (2007) Intake and bioaccessibility of total polyphenols in a whole diet. Food Chemistry 101: 492-501. (Pubitemid 44349109)
16. Pérez-Berezo T, Ramiro-Puig E, Pérez-Cano FJ, Castellote C, Permanyer J, et al. (2009) Influence of a cocoa-enriched diet on specific immune response in ovalbumin-sensitized rats. Mol Nutr Food Res 53: 389-397.
17. Okada Y, Oh-oka K, Nakamura Y, Ishimaru K, Matsuoka S, et al. (2012) Dietary resveratrol prevents the development of food allergy in mice. PLoS One. 7: e44338.
18. Mabalirajan U, Ahmad T, Rehman R, Leishangthem GD, Dinda AK, et al. (2013) Baicalein reduces airway injury in allergen and IL-13 induced airway inflammation. PLoS One 8: e62916.
19. Ci X, Chu X, Wei M, Yang X, Cai Q, et al. (2012) Different effects of farrerol on an OVA-induced allergic asthma and LPS-induced acute lung injury. PLoS One 7: e34634.
20. Singh A, Holvoet S, Mercenier A (2011) Dietary polyphenols in the prevention and treatment of allergic diseases. Clinical and Experimental Allergy 41: 1346-1359.
21. Haslam E (1996) Natural polyphenols (vegetable tannins) as drugs: possible modes of action. Journal of Natural Products 59: 205-215.
22. Seyoum A, Asres K, El-Fiky FK (2006) Structure-radical scavenging activity relationships of flavonoids. Phytochemistry 67: 2058-2070. (Pubitemid 44301284)
23. Di Carlo G, Mascolo N, Izzo AA, Capasso F (1999) Flavonoids: old and new aspects of a class of natural therapeutic drugs. Life Sciences 65: 337-353. (Pubitemid 29325278)
24. Dimitrios B (2006) Sources of natural phenolic antioxidants. Trends in Food Science & Technology 17: 505-512.
25. Han AR, Kim HJ, Shin M, Hong M, Kim YS, et al. (2008) Constituents of Asarum sieboldii with inhibitory activity on lipopolysaccharide (LPS)-induced NO production in BV-2 microglial cells. Chem Biodivers 5: 346-351.
26. Lee W, Ku SK, Kim JA, Lee T, Bae JS (2013) Inhibitory effects of epi-sesamin on HMGB1-induced vascular barrier disruptive responses in vitro and in vivo. Toxicology and Applied Pharmacology 267: 201-208.
27. Fukuda Y, Nagata M, Osawa T, Namiki M (1986) Chemical aspects of the antioxidative activity of roasted sesame seed oil, and the effect of using the oil for frying. Agricultural and Biological Chemistry 50: 857-862.
28. Bournival J, Plouffe M, Renaud J, Provencher C, Martinoli MG (2012) Quercetin and sesamin protect dopaminergic cells from MPP+-induced neuroinflammation in a microglial (N9)-neuronal (PC12) coculture system. Oxid Med Cell Longev 2012: 921-941.
29. Noguchi T, Ikeda K, Sasaki Y, Yamamoto J, Yamori Y (2004) Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Clinical and Experimental Pharmacology and Physiology 31 Suppl 2: S24-26.
30. Lee CC, Chen PR, Lin S, Tsai SC, Wang BW, et al. (2004) Sesamin induces nitric oxide and decreases endothelin-1 production in HUVECs: possible implications for its antihypertensive effect. Journal of Hypertension 22: 2329-2338. (Pubitemid 39620283)
31. Huang F, Zhang H, Wu M, Yang H, Kudo M, et al. (2012) Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction. Proceedings of the National Academy of Sciences of the United States of America 109: 16354-16359.
32. Voynow JA, Fischer BM, Malarkey DE, Burch LH, Wong T, et al. (2004) Neutrophil elastase induces mucus cell metaplasia in mouse lung. Am J Physiol Lung Cell Mol Physiol 287: L1293-1302. (Pubitemid 39507209)
33. Hsu WH, Lee BH, Huang YC, Hsu YW, Pan TM (2012) Ankaflavin, a novel Nrf-2 activator for attenuating allergic airway inflammation. Free Radical Biology and Medicine 53: 1643-1651.
34. Aich J, Mabalirajan U, Ahmad T, Khanna K, Rehman R, et al. (2012) Resveratrol attenuates experimental allergic asthma in mice by restoring inositol polyphosphate 4 phosphatase (INPP4A). Int Immunopharmacol 14: 438-443.
35. Henderson WR, Jr., Banerjee ER, Chi EY (2005) Differential effects of (S)- and (R)-enantiomers of albuterol in a mouse asthma model. Journal of Allergy and Clinical Immunology 116: 332-340. (Pubitemid 41096540)
36. Liu CJ, Cheng YC, Lee KW, Hsu HH, Chu CH, et al. (2008) Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signaling pathway in H9c2 myocardiac cells. Molecular and Cellular Biochemistry 313: 167-178.
37. Pichavant M, Goya S, Hamelmann E, Gelfand EW, Umetsu DT (2007) Animal models of airway sensitization. Curr Protoc Immunol 79: 15.18.1-15.18.19.
38. Lee JJ, Dimina D, Macias MP, Ochkur SI, McGarry MP, et al. (2004) Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305: 1773-1776. (Pubitemid 39249644)
39. Menzies-Gow A, Robinson DS (2002) Eosinophils, eosinophilic cytokines (interleukin-5), and antieosinophilic therapy in asthma. Current Opinion in Pulmonary Medicine 8: 33-38. (Pubitemid 34014512)
40. Aikawa T, Shimura S, Sasaki H, Ebina M, Takishima T (1992) Marked goblet cell hyperplasia with mucus accumulation in the airways of patients who died of severe acute asthma attack. Chest 101: 916-921.
41. Thai P, Loukoianov A, Wachi S, Wu R (2008) Regulation of airway mucin gene expression. Annu Rev Physiol 70: 405-429. (Pubitemid 351738186)
42. Fujisawa T, Chang MM, Velichko S, Thai P, Hung LY, et al. (2010) NF-κB mediates IL-1β- and IL-17A-induced MUC5B expression in airway epithelial cells. Am J Respir Cell Mol Biol 45: 246-252.
43. Rogers DF (2007) Physiology of airway mucus secretion and pathophysiology of hypersecretion. Respiratory Care 52: 1134-1149.
44. Christman JW, Sadikot RT, Blackwell TS (2000) The role of nuclear factor-kappa B in pulmonary diseases. Chest 117: 1482-1487. (Pubitemid 30321607)
45. Zosky GR, Sly PD (2007) Animal models of asthma. Clinical and Experimental Allergy 37: 973-988. (Pubitemid 46955517)
46. Holt PG, Batty JE, Turner KJ (1981) Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 42: 409-417. (Pubitemid 11094416)
47. Bargatze RF, Katz DH (1980) "Allergic breakthrough" after antigen sensitization: height of IgE synthesis is temporally related to diurnal variation in endogenous steroid production. J Immunol 125: 2306-2310. (Pubitemid 10022983)
48. Diamant Z, Tufvesson E, Bjermer L (2013) Which Biomarkers Are Effective for Identifying Th2-Driven Inflammation in Asthma? Curr Allergy Asthma Rep. 13: 477-486.
49. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, et al. (2009) T-helper type 2-driven inflammation defines major subphenotypes of asthma. American Journal of Respiratory and Critical Care Medicine 180: 388-395.
50. Kay AB (2006) The role of T lymphocytes in asthma. Chem Immunol Allergy 91: 59-75.
51. Barnes PJ (2008) Immunology of asthma and chronic obstructive pulmonary disease. Nat Rev Immunol 8: 183-192.
52. Dar AA, Arumugam N (2013) Lignans of sesame: Purification methods, biological activities and biosynthesis - A review. Bioorg Chem 50: 1-10.
53. Hirose N, Doi F, Ueki T, Akazawa K, Chijiiwa K, et al. (1992) Suppressive effect of sesamin against 7,12-dimethylbenz[a]-anthracene induced rat mammary carcinogenesis. Anticancer Research 12: 1259-1265.
54. Akimoto K, Kitagawa Y, Akamatsu T, Hirose N, Sugano M, et al. (1993) Protective effects of sesamin against liver damage caused by alcohol or carbon tetrachloride in rodents. Annals of Nutrition and Metabolism 37: 218-224. (Pubitemid 23240775)
55. Matsumura Y, Kita S, Morimoto S, Akimoto K, Furuya M, et al. (1995) Antihypertensive effect of sesamin. I. Protection against deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy. Biological and Pharmaceutical Bulletin 18: 1016-1019.
56. Chavali SR, Utsunomiya T, Forse RA (2001) Increased survival after cecal ligation and puncture in mice consuming diets enriched with sesame seed oil. Critical Care Medicine 29: 140-143. (Pubitemid 32125788)
57. Lee CC, Liu KJ, Wu YC, Lin SJ, Chang CC, et al. (2011) Sesamin inhibits macrophage-induced vascular endothelial growth factor and matrix metallo-proteinase-9 expression and proangiogenic activity in breast cancer cells. Inflammation 34: 209-221.
58. Cui Y, Hou X, Chen J, Xie L, Yang L, et al. (2010) Sesamin inhibits bacterial formylpeptide-induced inflammatory responses in a murine air-pouch model and in THP-1 human monocytes. Journal of Nutrition 140: 377-381.
59. Lee WJ, Ou HC, Wu CM, Lee IT, Lin SY, et al. (2009) Sesamin mitigates inflammation and oxidative stress in endothelial cells exposed to oxidized lowdensity lipoprotein. Journal of Agricultural and Food Chemistry 57: 11406-11417.
60. Hsieh PF, Hou CW, Yao PW, Wu SP, Peng YF, et al. (2011) Sesamin ameliorates oxidative stress and mortality in kainic acid-induced status epi lept icus by inhibi t ion of MAPK and COX-2 activat ion. J Neuroinflammation 8: 57.
61. Busse WW, Lemanske RF (2001) Asthma. New England Journal of Medicine 344: 350-362. (Pubitemid 32107645)
62. Harikumar KB, Sung B, Tharakan ST, Pandey MK, Joy B, et al. (2010) Sesamin manifests chemopreventive effects through the suppression of NF-kappa Bregulated cell survival, proliferation, invasion, and angiogenic gene products. Mol Cancer Res 8: 751-761.
63. Baldwin AS, Jr. (2001) Series introduction: the transcription factor NF-kappaB and human disease. Journal of Clinical Investigation 107: 3-6.
64. Jeng KC, Hou RC, Wang JC, Ping LI (2005) Sesamin inhibits lipopolysaccha-ride-induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Immunology Letters 97: 101-106. (Pubitemid 40038860)
65. Wu WH, Wang SH, Kuan II, Kao YS, Wu PJ, et al. (2010) Sesamin attenuates intercellular cell adhesion molecule-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in apolipoprotein-E-deficient mice. Mol Nutr Food Res 54: 1340-1350.
66. Baroffio M, Barisione G, Crimi E, Brusasco V (2009) Noninflammatory mechanisms of airway hyper-responsiveness in bronchial asthma: an overview. Ther Adv Respir Dis 3: 163-174.
67. Chapman ID, FosterA, Morley J (1993) The relationship between inflammation and hyperreactivity of the airways in asthma. Clinical and Experimental Allergy 23: 168-171. (Pubitemid 23112337)
68. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, et al. (2000) Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356: 2144-2148.
69. Lundgren R, Soderberg M, Horstedt P, Stenling R (1988) Morphological studies of bronchial mucosal biopsies from asthmatics before and after ten years of treatment with inhaled steroids. European Respiratory Journal 1: 883-889. (Pubitemid 19015298)